Journal for ImmunoTherapy of Cancer (Nov 2023)
897-F Wnt inhibition improves efficacy of immune checkpoint blockade in glioblastoma
- Dai Fukumura,
- Rakesh K Jain,
- Peigen Huang,
- Lance L Munn,
- Patrik Andersson,
- Zohreh Amoozgar,
- Somin Lee,
- Meenal Datta,
- Sylvie Roberge,
- Mark Duquette,
- Neal I Lindeman,
- Shanmugarajan Krishnan,
- Sonu Subudhi,
- Ashwin Srinivasan Kumar,
- Jessica Posada,
- Pinji Lei
Affiliations
- Dai Fukumura
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Rakesh K Jain
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Peigen Huang
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Lance L Munn
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Patrik Andersson
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Zohreh Amoozgar
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Somin Lee
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Meenal Datta
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Sylvie Roberge
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Mark Duquette
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Neal I Lindeman
- 2Brigham and Women’s Hospital, Boston, MA, USA
- Shanmugarajan Krishnan
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Sonu Subudhi
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Ashwin Srinivasan Kumar
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Jessica Posada
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- Pinji Lei
- 1Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA
- DOI
- https://doi.org/10.1136/jitc-2023-SITC2023.0897-F
- Journal volume & issue
-
Vol. 11,
no. Suppl 2
Abstract
No abstracts available.